Literature DB >> 8421107

Abnormal facilitative glucose transporter gene expression in human islet cell tumors.

Y Seino1, T Yamamoto, K Inoue, M Imamura, S Kadowaki, H Kojima, J Fujikawa, H Imura.   

Abstract

Our previous studies have shown that increased expression of GLUT1/erythrocyte and GLUT3/brain type glucose transporter genes in human tumors is associated with cellular transformation. We have now determined the levels of messenger RNAs (mRNAs) encoding these two glucose transporter isoforms as well as that of GLUT2/liver isoform in insulin-, glucagon-, and gastrin-secreting islet cell tumors. Northern blot analysis and reverse transcriptase-polymerase chain reaction revealed the presence of GLUT1 and GLUT3 mRNA in all human islet cell tumors and normal islets examined. In contrast, GLUT2 mRNA, which is present at high levels in normal islets, was not detected in insulinomas or other types of islet cell tumors. These results imply that GLUT1 and GLUT3 are primarily responsible for glucose uptake by these tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421107     DOI: 10.1210/jcem.76.1.8421107

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Using the Secretion Ratios of Insulin and C-peptide During the 2-h Oral Glucose Tolerance Test to Diagnose Insulinoma.

Authors:  Jing Liao; Fei Ding; Wei Luo; Xin Nie; Yong He; Guixing Li
Journal:  Dig Dis Sci       Date:  2020-06-11       Impact factor: 3.199

2.  Inhibition of the high-affinity glucose transporter GLUT 1 affects the sensitivity to glucose in a hamster-derived pancreatic beta cell line (HIT).

Authors:  A M Rabuazzo; M Buscema; C Vinci; V Caltabiano; M Anello; R Vigneri; F Purrello
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

Review 3.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

4.  Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.

Authors:  A De Vos; H Heimberg; E Quartier; P Huypens; L Bouwens; D Pipeleers; F Schuit
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  Immunocytochemical Localization of Glucose Transporter-2 (GLUT-2) in Pancreatic Islets and Islet Cell Tumors.

Authors:  Tatsuo Tomita
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

6.  Insulinoma Presenting with Reactive Hypoglycemia: Evaluating the Effect of Tumor Resection via Continuous Glucose Monitoring.

Authors:  Tomohiko Kikuchi; Daisuke Chujo; Kazuhisa Takahashi; Nobuyuki Takahashi; Yuuki Tanno; Mie Tonoike; Noriko Ihana; Tetsuro Tsujimoto; Akiyo Tanabe; Hiroshi Kajio
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

7.  Glucose-responsive Insulinoma with Insulin Hypersecretion Suppressed by Metformin.

Authors:  Kunihisa Hamano; Kayo Akita; Yoko Takeuchi; Tetsuya Suwa; Jun Takeda; Shuji Dodo
Journal:  Intern Med       Date:  2019-08-28       Impact factor: 1.271

8.  Glucose transporters as markers of diagnosis and prognosis in cancer diseases.

Authors:  Leszek Szablewski
Journal:  Oncol Rev       Date:  2022-02-22

9.  A Clinical Case of Insulinoma Presenting with Postprandial Hypoglycemia in a Patient with a History of Gastric Bypass Surgery.

Authors:  Ryosuke Hayashida; Kyoichiro Tsuchiya; Tetsuo Sekine; Takashi Momose; Fuminori Sato; Maya Sakurada; Kenji Nishida; Tatsuya Hayashi; Yasuhiro Morita; Haruka Okada; Noriyoshi Fukushima; Tetsuya Yamada; Motoyoshi Tsujino
Journal:  Intern Med       Date:  2021-10-12       Impact factor: 1.282

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.